|
US20010031244A1
(en)
*
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
|
CA2347856C
(en)
*
|
1998-11-13 |
2009-02-17 |
Jago Research Ag |
Dry powder for inhalation
|
|
US20070212422A1
(en)
*
|
1999-11-10 |
2007-09-13 |
Manfred Keller |
Dry powder for inhalation
|
|
DZ2947A1
(fr)
*
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
|
IT1309592B1
(it)
|
1999-03-05 |
2002-01-24 |
Chiesi Farma Spa |
Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e
|
|
PT1158958E
(pt)
*
|
1999-03-05 |
2007-08-13 |
Chiesi Farma Spa |
''composições farmacêuticas em pó, melhoradas, para inalação''
|
|
US7258850B2
(en)
*
|
1999-05-04 |
2007-08-21 |
Aradigm Corporation |
Methods and compositions for treating erectile dysfunction
|
|
US20040002548A1
(en)
*
|
1999-05-12 |
2004-01-01 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
|
US6315985B1
(en)
*
|
1999-06-18 |
2001-11-13 |
3M Innovative Properties Company |
C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
|
|
ITMI991582A1
(it)
|
1999-07-16 |
2001-01-16 |
Chiesi Farma Spa |
Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
|
|
IT1313553B1
(it)
|
1999-07-23 |
2002-09-09 |
Chiesi Farma Spa |
Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
|
|
DE19947235A1
(de)
*
|
1999-09-30 |
2001-04-05 |
Asta Medica Ag |
Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten
|
|
AU7685200A
(en)
*
|
1999-10-12 |
2001-04-23 |
Kaken Pharmaceutical Co., Ltd. |
Powdery inhalational preparations and process for producing the same
|
|
IT1317720B1
(it)
*
|
2000-01-07 |
2003-07-15 |
Chiesi Farma Spa |
Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
|
|
IT1317846B1
(it)
*
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
|
GB0008660D0
(en)
*
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
|
ATE364381T1
(de)
*
|
2000-04-17 |
2007-07-15 |
Vectura Ltd |
Formulierungen zur verwendung in inhalationsvorrichtungen
|
|
GB0009468D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formulations for use in inhaler devices
|
|
GB0009469D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formalities for use in inhaler devices
|
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
|
IT1318514B1
(it)
*
|
2000-05-12 |
2003-08-27 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
|
|
GB0012261D0
(en)
|
2000-05-19 |
2000-07-12 |
Astrazeneca Ab |
Novel process
|
|
GB0012260D0
(en)
|
2000-05-19 |
2000-07-12 |
Astrazeneca Ab |
Novel composition
|
|
SK286694B6
(sk)
*
|
2000-05-22 |
2009-03-05 |
Chiesi Farmaceutici S.P.A. |
Aerosólový farmaceutický prostriedok
|
|
KR100949539B1
(ko)
|
2000-06-27 |
2010-03-25 |
벡투라 리미티드 |
약학 조성물용 입자의 제조 방법
|
|
AU6926101A
(en)
*
|
2000-06-27 |
2002-01-08 |
Vectura Ltd |
Method of making particles for use in a pharmaceutical composition
|
|
EP1292281B1
(de)
*
|
2000-10-12 |
2004-09-08 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Neue tiotropium-haltige inhalationspulver
|
|
UA75375C2
(en)
*
|
2000-10-12 |
2006-04-17 |
Boehringer Ingelheim Pharma |
Method for producing powdery preparations for inhaling
|
|
US20020183292A1
(en)
*
|
2000-10-31 |
2002-12-05 |
Michel Pairet |
Pharmaceutical compositions based on anticholinergics and corticosteroids
|
|
EP1337241B1
(en)
†
|
2000-11-30 |
2008-01-02 |
Vectura Limited |
Method of preparing microparticles for use in pharmaceutical compositions for inhalation
|
|
EP1920763B2
(en)
|
2000-11-30 |
2022-06-15 |
Vectura Limited |
Pharmaceutical compositions for inhalation
|
|
ES2689704T3
(es)
*
|
2000-11-30 |
2018-11-15 |
Vectura Limited |
Partículas para usar en una composición farmacéutica
|
|
GB0107106D0
(en)
*
|
2001-03-21 |
2001-05-09 |
Boehringer Ingelheim Pharma |
Powder inhaler formulations
|
|
US20030055026A1
(en)
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
|
WO2003026631A1
(en)
*
|
2001-05-24 |
2003-04-03 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
|
US20030051728A1
(en)
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
|
CA2446904A1
(en)
|
2001-05-24 |
2003-04-03 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
|
US20030013675A1
(en)
*
|
2001-05-25 |
2003-01-16 |
Boehringer Ingelheim Pharma Kg |
Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
|
|
US20030070679A1
(en)
*
|
2001-06-01 |
2003-04-17 |
Boehringer Ingelheim Pharma Kg |
Capsules containing inhalable tiotropium
|
|
DE10126924A1
(de)
*
|
2001-06-01 |
2002-12-05 |
Boehringer Ingelheim Pharma |
Inhalationskapseln
|
|
DE10130371A1
(de)
*
|
2001-06-23 |
2003-01-02 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
|
|
ES2222294T3
(es)
*
|
2001-07-02 |
2005-02-01 |
Chiesi Farmaceutici S.P.A. |
Formulacion optimizada de tobramicina para administracion en forma de aerosol.
|
|
US20040244794A1
(en)
*
|
2001-08-09 |
2004-12-09 |
Richards David Hugh |
Inhalation device with a pharmaceutical composition
|
|
AU2002333644A1
(en)
|
2001-09-17 |
2003-04-01 |
Glaxo Group Limited |
Dry powder medicament formulations
|
|
PT3494995T
(pt)
*
|
2002-03-01 |
2020-03-30 |
Chiesi Farm Spa |
Formulação superfina de formoterol
|
|
DE10212264A1
(de)
*
|
2002-03-20 |
2003-10-02 |
Boehringer Ingelheim Pharma |
Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
|
|
NZ536277A
(en)
*
|
2002-04-04 |
2006-03-31 |
Boehringer Ingelheim Pharma |
Powder formulations containing tiotropium suitable for inhalation
|
|
US20030235538A1
(en)
*
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
|
UA80123C2
(en)
*
|
2002-04-09 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Inhalation kit comprising inhalable powder of tiotropium
|
|
GB0208608D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
|
AU2003269889B2
(en)
*
|
2002-06-17 |
2007-04-19 |
Epigenesis Pharmaceuticals, Llc |
Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
|
|
US7078423B2
(en)
|
2002-07-18 |
2006-07-18 |
Inotek Pharmaceuticals Corporation |
5-Aryltetrazole compounds, compositions thereof, and uses therefor
|
|
US7087631B2
(en)
|
2002-07-18 |
2006-08-08 |
Inotek Pharmaceuticals Corporation |
Aryltetrazole compounds, and compositions thereof
|
|
GB0219513D0
(en)
*
|
2002-08-21 |
2002-10-02 |
Norton Healthcare Ltd |
Inhalation compositions including coarse carrier
|
|
JP2006516531A
(ja)
*
|
2002-08-21 |
2006-07-06 |
ノートン ヘルスケアー リミテッド |
吸入組成物
|
|
US20050158248A1
(en)
*
|
2002-08-21 |
2005-07-21 |
Xian-Ming Zeng |
Method of preparing dry powder inhalation compositions
|
|
GB0219511D0
(en)
*
|
2002-08-21 |
2002-10-02 |
Norton Healthcare Ltd |
Method of preparing dry powder inhalation compositions
|
|
GB0219512D0
(en)
*
|
2002-08-21 |
2002-10-02 |
Norton Healthcare Ltd |
Inhalation compositions with high drug ratios
|
|
EP1599209B1
(en)
*
|
2002-08-21 |
2011-08-17 |
Norton Healthcare Limited |
Inhalation composition
|
|
AU2003260754B2
(en)
*
|
2002-08-29 |
2009-12-03 |
Cipla Limited |
Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
|
|
SE0203376D0
(sv)
*
|
2002-11-15 |
2002-11-15 |
Astrazeneca Ab |
New process
|
|
US7763280B2
(en)
*
|
2002-11-28 |
2010-07-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Tiotropium containing powder formulation for inhalation
|
|
DE10255387A1
(de)
*
|
2002-11-28 |
2004-06-09 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Tiotropium-haltige Pulverformulierung für die Inhalation
|
|
ES2626648T3
(es)
*
|
2002-12-10 |
2017-07-25 |
Sunovion Pharmaceuticals Inc. |
Composición farmacéutica que comprende sal L-hemitartrato de levalbuterol como formulación en aerosol
|
|
US7879833B2
(en)
*
|
2002-12-12 |
2011-02-01 |
Nycomed Gmbh |
Combination medicament
|
|
US20040152720A1
(en)
*
|
2002-12-20 |
2004-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
|
|
US20060147389A1
(en)
*
|
2004-04-14 |
2006-07-06 |
Vectura Ltd. |
Devices and pharmaceutical compositions for enhancing dosing efficiency
|
|
US20120321717A1
(en)
*
|
2003-04-14 |
2012-12-20 |
Vectura Ltd. |
Devices and pharmaceutical compositions for enhancing dosing efficiency
|
|
CN102688224A
(zh)
*
|
2003-04-14 |
2012-09-26 |
维克特拉有限公司 |
用于提高剂量效率的药物组合物和装置
|
|
DE10317461A1
(de)
*
|
2003-04-16 |
2004-10-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
|
|
CA2526475A1
(en)
|
2003-05-21 |
2004-12-02 |
Alexza Pharmaceuticals, Inc. |
Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
|
|
JP2006528228A
(ja)
*
|
2003-05-22 |
2006-12-14 |
アルタナ ファルマ アクチエンゲゼルシャフト |
サルメテロール及びシクレソニドの組合せ物
|
|
GB0312148D0
(en)
*
|
2003-05-28 |
2003-07-02 |
Aventis Pharma Ltd |
Stabilized pharmaceutical products
|
|
SE527200C2
(sv)
*
|
2003-06-19 |
2006-01-17 |
Microdrug Ag |
Inhalatoranordning samt kombinerade doser av formaterol och fluticason
|
|
SE527189C2
(sv)
*
|
2003-06-19 |
2006-01-17 |
Microdrug Ag |
Inhalatoranordning samt kombinerade doser för formaterol och ett antikolinergiskt medel
|
|
SE527069C2
(sv)
|
2003-06-19 |
2005-12-13 |
Mederio Ag |
Förfarande och anordning för administrering av läkemedelspulver
|
|
SE527190C2
(sv)
*
|
2003-06-19 |
2006-01-17 |
Microdrug Ag |
Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid
|
|
SE526509C2
(sv)
*
|
2003-06-19 |
2005-09-27 |
Microdrug Ag |
Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
|
|
SE526850C2
(sv)
*
|
2003-06-19 |
2005-11-08 |
Microdrug Ag |
Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd
|
|
GB0315889D0
(en)
*
|
2003-07-08 |
2003-08-13 |
Aventis Pharma Ltd |
Stable pharmaceutical products
|
|
TWI359675B
(en)
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|
|
US20060210485A1
(en)
*
|
2003-07-11 |
2006-09-21 |
Marian Thomas |
Pharmaceutical formulations
|
|
EP1643973A1
(en)
*
|
2003-07-11 |
2006-04-12 |
Glaxo Group Limited |
Pharmaceutical formulations comprising magnesium stearate
|
|
EP1646370A1
(en)
*
|
2003-07-11 |
2006-04-19 |
Glaxo Group Limited |
Pharmaceutical formulations
|
|
GB0316341D0
(en)
*
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
|
GB0321607D0
(en)
*
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
|
EP1670482B2
(en)
*
|
2003-09-16 |
2022-06-29 |
Covis Pharma B.V. |
Use of ciclesonide for the treatment of respiratory diseases
|
|
GB0323684D0
(en)
|
2003-10-09 |
2003-11-12 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
|
GB0324918D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Composition
|
|
JP2007509941A
(ja)
*
|
2003-10-28 |
2007-04-19 |
グラクソ グループ リミテッド |
ラクトース無水物を用いる吸入医薬製剤およびその投与方法
|
|
US20090246281A1
(en)
*
|
2003-11-03 |
2009-10-01 |
Norton Healthcare Ltd. |
Soft steroid compositions for use in dry powder inhalers
|
|
DE10352277A1
(de)
*
|
2003-11-08 |
2005-06-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulverinhalator
|
|
GB0326632D0
(en)
*
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
|
EP1691782A1
(en)
*
|
2003-12-03 |
2006-08-23 |
Microdrug AG |
Medical product containing tiotropium
|
|
SE0303570L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Fukt-känslig medicinsk produkt
|
|
SE0303269L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Medicinsk produkt
|
|
SE0303270L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
|
WO2005058280A2
(en)
*
|
2003-12-12 |
2005-06-30 |
Myogen, Inc. |
Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
|
|
PT1713473E
(pt)
*
|
2004-02-06 |
2013-05-13 |
Meda Pharma Gmbh & Co Kg |
Combinação de anticolinérgicos e glucocorticóides para o tratamento a longo prazo de asma e copd
|
|
SI1713471T1
(sl)
*
|
2004-02-06 |
2012-07-31 |
Meda Pharma Gmbh & Co Kg |
Kombinacija antiholinergikov in inhibitorjev fosfodiesteraze tipa za zdravljenje respiratornih bolezni
|
|
RU2438660C2
(ru)
*
|
2004-02-06 |
2012-01-10 |
Меда Фарма Гмбх Унд Ко. Кг |
Комбинация и фармацевтический препарат для лечения воспалительных и обструктивных заболеваний дыхательных путей
|
|
US20070185067A1
(en)
*
|
2004-02-27 |
2007-08-09 |
Altana Pharma Ag |
Ciclesonide and glycopyrronium combination
|
|
EP1595531A1
(en)
|
2004-05-13 |
2005-11-16 |
CHIESI FARMACEUTICI S.p.A. |
Stable pharmaceutical solution formulations for pressurized metered dose inhalers
|
|
JP2007530563A
(ja)
*
|
2004-03-22 |
2007-11-01 |
ミオゲン インコーポレイティッド |
（ｓ）−エノキシモンスルホキシドおよびｐｄｅ−ｉｉｉ媒介疾患の治療におけるその使用
|
|
US20060030611A1
(en)
*
|
2004-03-22 |
2006-02-09 |
Myogen, Inc. |
Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
|
|
AU2005235384B2
(en)
*
|
2004-04-20 |
2010-09-09 |
Covis Pharma B.V. |
Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
|
|
RU2006141358A
(ru)
|
2004-04-23 |
2008-05-27 |
Сайдекс, Инк. (Us) |
Препаративная форма для ингалятора сухого порошка, содержащая простой сульфоалкиловый эфир циклодекстрина
|
|
GB0409703D0
(en)
|
2004-04-30 |
2004-06-02 |
Vectura Ltd |
Pharmaceutical compositions
|
|
GB0410399D0
(en)
*
|
2004-05-10 |
2004-06-16 |
Arakis Ltd |
The treatment of respiratory disease
|
|
GB0410398D0
(en)
*
|
2004-05-10 |
2004-06-16 |
Arakis Ltd |
The treatment of respiratory disease
|
|
GB0411056D0
(en)
|
2004-05-18 |
2004-06-23 |
Novartis Ag |
Organic compounds
|
|
SE530006C2
(sv)
*
|
2004-06-18 |
2008-02-05 |
Mederio Ag |
Inhalator som använder balja
|
|
WO2006007213A1
(en)
*
|
2004-06-23 |
2006-01-19 |
Myogen, Inc. |
Enoximone formulations and their use in the treatment of pde-iii mediated diseases
|
|
US20080027034A1
(en)
*
|
2004-09-10 |
2008-01-31 |
Shah Tushar P |
Ciclesonide and Syk Inhibitor Combination and Method of Use Thereof
|
|
GB0425758D0
(en)
|
2004-11-23 |
2004-12-22 |
Vectura Ltd |
Preparation of pharmaceutical compositions
|
|
US8343467B2
(en)
|
2004-12-27 |
2013-01-01 |
Beiersdorf Ag |
Glycopyrrolate in cosmetic preparations
|
|
DE102005029385B4
(de)
*
|
2005-06-23 |
2018-12-27 |
Beiersdorf Ag |
Wirkstoffkombinationen aus Glycopyrroniumbromid und Chitosan
|
|
JP3955868B2
(ja)
*
|
2004-12-27 |
2007-08-08 |
株式会社キングジム |
書類等の綴じ具
|
|
CA2600636A1
(en)
*
|
2005-03-09 |
2006-09-14 |
Boehringer Ingelheim International Gmbh |
New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
|
|
MX2007011273A
(es)
*
|
2005-03-16 |
2007-11-08 |
Meda Pharma Gmbh & Co Kg |
La combinacion de anticolinergicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias.
|
|
WO2006105401A2
(en)
*
|
2005-03-30 |
2006-10-05 |
Schering Corporation |
Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist
|
|
WO2006114379A1
(de)
*
|
2005-04-23 |
2006-11-02 |
Boehringer Ingelheim International Gmbh |
Arzneimittelkombination für die inhalation enthaltend neben einem anticholinergikum ein betamimetikum und ein steroid
|
|
US20060239935A1
(en)
*
|
2005-04-23 |
2006-10-26 |
Boehringer Ingelheim International Gmbh |
Compositions for inhalation
|
|
TWI274641B
(en)
*
|
2005-08-30 |
2007-03-01 |
Rexon Ind Corp Ltd |
Cutting machine
|
|
GB0520794D0
(en)
*
|
2005-10-12 |
2005-11-23 |
Innovata Biomed Ltd |
Inhaler
|
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
|
GB0525254D0
(en)
*
|
2005-12-12 |
2006-01-18 |
Jagotec Ag |
Powder compositions for inhalation
|
|
AU2006329042B2
(en)
|
2005-12-21 |
2012-02-02 |
Meda Pharma Gmbh & Co Kg |
Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases
|
|
AU2012200449B2
(en)
*
|
2005-12-21 |
2013-07-25 |
Meda Pharma Gmbh & Co Kg |
Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases
|
|
EP1803457A1
(en)
*
|
2005-12-30 |
2007-07-04 |
Krka Tovarna Zdravil, D.D., Novo Mesto |
Pharmaceutical composition containing montelukast
|
|
SI1976522T2
(sl)
*
|
2005-12-30 |
2019-11-29 |
Krka Tovarna Zdravil D D Novo Mesto |
Farmacevtski sestavek, ki vsebuje montelukast
|
|
GB0602897D0
(en)
*
|
2006-02-13 |
2006-03-22 |
Jagotec Ag |
Improvements In Or Relating To Dry Powder Inhaler Devices
|
|
GB0606124D0
(en)
|
2006-03-28 |
2006-05-03 |
Reckitt Benckiser Healthcare |
Buprenorphine derivatives and uses thereof
|
|
GB0613161D0
(en)
|
2006-06-30 |
2006-08-09 |
Novartis Ag |
Organic Compounds
|
|
DK2046787T3
(da)
|
2006-08-01 |
2011-07-18 |
Glaxo Group Ltd |
Pyrazolo[3,4-B]pyridin-forbindelser, og deres anvendelse som PDE4-inhibitorer
|
|
RU2338552C2
(ru)
*
|
2006-09-19 |
2008-11-20 |
Владимир Евгеньевич Небольсин |
Фармацевтическая композиция для ингаляции
|
|
GB0622818D0
(en)
*
|
2006-11-15 |
2006-12-27 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
|
GB0625303D0
(en)
*
|
2006-12-19 |
2007-01-24 |
Jagotec Ag |
Improvements in and relating to metered dose inhalers
|
|
ES2594867T3
(es)
|
2007-03-09 |
2016-12-23 |
Alexza Pharmaceuticals, Inc. |
Unidad de calentamiento para usar en un dispositivo de administración de fármaco
|
|
US8415390B2
(en)
|
2008-05-30 |
2013-04-09 |
Microdose Therapeutx, Inc. |
Methods and compositions for administration of oxybutynin
|
|
US9119777B2
(en)
|
2008-05-30 |
2015-09-01 |
Microdose Therapeutx, Inc. |
Methods and compositions for administration of oxybutynin
|
|
GB0716026D0
(en)
*
|
2007-08-16 |
2007-09-26 |
Norton Healthcare Ltd |
An inhalable medicament
|
|
US20110253140A1
(en)
*
|
2008-07-30 |
2011-10-20 |
Stc.Unm |
Formulations containing large-size carrier particles for dry powder inhalation aerosols
|
|
EP2172190A1
(en)
*
|
2008-10-02 |
2010-04-07 |
Laboratorios Liconsa, S.A. |
Inhalable particles comprising tiotropium
|
|
CA2744655A1
(en)
*
|
2008-11-27 |
2010-06-03 |
Boehringer Ingelheim International Gmbh |
Novel powdered crystalline medicines for inhalation
|
|
EP2201977A1
(de)
|
2008-12-23 |
2010-06-30 |
Siegfried Generics International AG |
Dosiervorrichtung zur Erzeugung eines Gasstromes mit einem in diesem fein verteilten Wirkstoff
|
|
US9925282B2
(en)
|
2009-01-29 |
2018-03-27 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
ES2739352T3
(es)
|
2009-02-26 |
2020-01-30 |
Glaxo Group Ltd |
Formulaciones farmacéuticas que comprenden 4-{(1R)-2-[(6-{2-[(2,6-diclorobencil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol
|
|
RU2580315C3
(ru)
|
2009-05-29 |
2021-06-18 |
Перл Терапьютикс, Инк. |
Композиции для респираторной доставки активных веществ и связанные с ними способы и системы
|
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
|
AU2010260513A1
(en)
*
|
2009-06-16 |
2012-02-02 |
Wen Tan |
Use of R-Bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
|
|
AU2009100698B4
(en)
*
|
2009-07-17 |
2010-04-15 |
Astrazeneca Ab |
Combination
|
|
GB0918149D0
(en)
|
2009-10-16 |
2009-12-02 |
Jagotec Ag |
Improved medicinal aerosol formulation
|
|
GB0918249D0
(en)
|
2009-10-19 |
2009-12-02 |
Respivert Ltd |
Compounds
|
|
GB0918450D0
(en)
|
2009-10-21 |
2009-12-09 |
Innovata Ltd |
Composition
|
|
US9433588B2
(en)
|
2009-11-09 |
2016-09-06 |
Virginia Commonwealth Univeristy |
Delivery of submicrometer and nanometer aerosols to the lungs using hygroscopic excipients or dual stream nasal delivery
|
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
|
BR112012015335B1
(pt)
*
|
2009-12-23 |
2021-05-18 |
Chiesi Farmaceutici S.P.A. |
formulação de aerossol para doença pulmonar obstrutiva crõnica
|
|
US8834931B2
(en)
|
2009-12-25 |
2014-09-16 |
Mahmut Bilgic |
Dry powder formulation containing tiotropium for inhalation
|
|
TR201000679A2
(tr)
*
|
2010-01-29 |
2011-08-22 |
B�Lg�� Mahmut |
Farmasötik bir kombinasyon içeren kuru toz formülasyonları.
|
|
WO2011120779A1
(en)
|
2010-04-01 |
2011-10-06 |
Chiesi Farmaceutici S.P.A. |
Process for preparing carrier particles for dry powders for inhalation
|
|
EP2560611B1
(en)
|
2010-04-21 |
2018-01-03 |
Chiesi Farmaceutici S.p.A. |
"process for providing particles with reduced electrostatic charges"
|
|
EP2611416B1
(en)
|
2010-09-03 |
2015-08-19 |
Pharmaterials Ltd. |
Pharmaceutical composition suitable for use in a dry powder inhaler
|
|
WO2012041717A1
(en)
*
|
2010-09-30 |
2012-04-05 |
Chiesi Farmaceutici S.P.A. |
Use of magnesium stearate in dry powder formulations for inhalation
|
|
UY33337A
(es)
|
2010-10-18 |
2011-10-31 |
Respivert Ltd |
DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS
|
|
JO3510B1
(ar)
|
2011-03-04 |
2020-07-05 |
Heptares Therapeutics Ltd |
استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
|
|
IN2014CN03555A
(pt)
|
2011-10-25 |
2015-07-03 |
Onclave Therapeutics Ltd |
|
|
GB201200525D0
(en)
|
2011-12-19 |
2012-02-29 |
Teva Branded Pharmaceutical Prod R & D Inc |
An inhalable medicament
|
|
RS63706B1
(sr)
|
2012-01-25 |
2022-11-30 |
Chiesi Farm Spa |
Formulacija suvog praha koja sadrži kortikosteroid i beta-adrenergik, za primenu inhalacijom
|
|
US20150010527A1
(en)
|
2012-02-01 |
2015-01-08 |
Protalix Ltd. |
Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
|
|
US10463815B2
(en)
|
2012-02-21 |
2019-11-05 |
Respira Therapeutics, Inc. |
Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
|
|
MX355299B
(es)
|
2012-03-13 |
2018-04-11 |
Respivert Ltd |
Inhibidores de cinasa de fosfoinositida 3 cristalina.
|
|
EP2641900A1
(en)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
|
|
RU2494730C1
(ru)
*
|
2012-03-27 |
2013-10-10 |
Шолекс Девелопмент Гмбх |
Ингаляционный препарат для лечения болезней органов дыхания, содержащий в качестве активных веществ микронизированный салметерол ксинофоат и микронизированный флутиказона пропионат и способ его получения
|
|
CA2869849A1
(en)
|
2012-04-13 |
2013-10-17 |
Glaxosmithkline Intellectual Property Development Limited |
Aggregate particles comprising nanoparticulate drug particles of umeclidinium bromide, vilanterol trifenatate and fluticasone furoate
|
|
WO2014007767A1
(en)
*
|
2012-07-05 |
2014-01-09 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Dry powder inhalers comprising a carrier other than lactose and a ternary component
|
|
WO2014007771A2
(en)
|
2012-07-05 |
2014-01-09 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Inhalation compositions comprising muscarinic receptor antagonist
|
|
EA201590019A1
(ru)
|
2012-07-05 |
2015-09-30 |
Арвен Айлак Санайи Ве Тиджарет А.С. |
Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы
|
|
US10111957B2
(en)
|
2012-07-05 |
2018-10-30 |
Arven Ilac Snayi ve Ticaret A.S. |
Inhalation compositions comprising glucose anhydrous
|
|
US9452139B2
(en)
|
2013-03-14 |
2016-09-27 |
Novartis Ag |
Respirable agglomerates of porous carrier particles and micronized drug
|
|
SG11201507286QA
(en)
|
2013-03-15 |
2015-10-29 |
Pearl Therapeutics Inc |
Methods and systems for conditioning of particulate crystalline materials
|
|
GB201305825D0
(en)
|
2013-03-28 |
2013-05-15 |
Vectura Ltd |
New use
|
|
EP2821061B1
(en)
*
|
2013-07-01 |
2017-12-20 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Novel inhalation formulations
|
|
PL3019153T3
(pl)
*
|
2013-07-11 |
2019-02-28 |
Chiesi Farmaceutici S.P.A. |
Preparat proszkowy zawierający środek antycholinergiczny, kortykosteroid i środek beta-adrenergiczny do podawania wziewnego
|
|
CN110305095A
(zh)
*
|
2013-10-22 |
2019-10-08 |
综合医院公司 |
色甘酸衍生物以及成像和治疗的相关方法
|
|
CN104644618A
(zh)
*
|
2013-11-19 |
2015-05-27 |
上海医药工业研究院 |
一种干粉吸入剂及其制备方法
|
|
GB201321712D0
(en)
*
|
2013-12-09 |
2014-01-22 |
Pharmachemie Bv |
Dry Powder Inhaler
|
|
US20150283070A1
(en)
*
|
2014-04-08 |
2015-10-08 |
Sansa Corporation (Barbados) Inc. |
Nicotine Formulations and Methods of Making the Same
|
|
US10034866B2
(en)
|
2014-06-19 |
2018-07-31 |
Teva Branded Pharmaceutical Products R&D, Inc. |
Inhalable medicament comprising tiotropium
|
|
WO2016005443A1
(en)
*
|
2014-07-09 |
2016-01-14 |
Arven Ilac Sanayi Ve Ticaret A.S. |
A process for the preparation of formulations for inhalation
|
|
CN107106641B
(zh)
|
2014-10-31 |
2021-12-21 |
葛兰素史密斯克莱知识产权发展有限公司 |
粉末制剂
|
|
JP2018501903A
(ja)
|
2015-01-14 |
2018-01-25 |
レスピラ セラピューティクス インコーポレイテッドＲｅｓｐｉｒａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
パウダー分散方法および装置
|
|
WO2017077488A1
(en)
*
|
2015-11-04 |
2017-05-11 |
Glenmark Pharmaceuticals Limited |
An inhalable fixed dose powder composition comprising glycopyrronium and formoterol
|
|
WO2017168174A1
(en)
|
2016-04-02 |
2017-10-05 |
N4 Pharma Uk Limited |
New pharmaceutical forms of sildenafil
|
|
TWI745396B
(zh)
|
2016-07-12 |
2021-11-11 |
日商鹽野義製藥股份有限公司 |
吸入用醫藥組成物
|
|
US20190240194A1
(en)
|
2016-08-31 |
2019-08-08 |
The General Hospital Corporation |
Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases
|
|
BR112019023386A2
(pt)
*
|
2017-05-11 |
2020-06-16 |
Chiesi Farmaceutici S.P.A. |
Processo para preparar uma formulação em pó para inalação para uso em um inalador de pó seco
|
|
CN108175764B
(zh)
*
|
2017-12-19 |
2020-02-21 |
亿腾医药（苏州）有限公司 |
一种无水二丙酸倍氯米松无菌粉末及其吸入混悬液的制备方法
|
|
EP3673895A1
(en)
*
|
2018-12-28 |
2020-07-01 |
Université Libre de Bruxelles |
Dry powder inhalation formulation and its use for the therapeutic treatment of lungs
|
|
CN113476428B
(zh)
*
|
2021-01-28 |
2022-03-29 |
朗天药业(湖北)有限公司 |
一种吸入用硫酸沙丁胺醇溶液及其制备方法
|
|
GR1010358B
(el)
*
|
2021-09-14 |
2022-12-16 |
Elpen Ανωνυμος Εταιρεια Φαρμακευτικη Βιομηχανια, |
Σταθερο φαρμακευτικο σκευασμα που περιεχει βρωμιουχο τιοτροπιο, για χορηγηση απο το αναπνευστικο
|
|
CN118475343A
(zh)
|
2021-12-21 |
2024-08-09 |
凯西制药公司 |
填充在具有改善的耐湿性的吸入器中的干粉制剂
|
|
WO2023117967A1
(en)
|
2021-12-21 |
2023-06-29 |
Chiesi Farmaceutici S.P.A. |
Dry powder formulations filled in an inhaler with improved resistance to humidity
|